Suchergebnisse

Qualitative design consists of various approaches towards data collection, which researchers can use to help with the provision of both cultural and contextual description and interpretation of social phenomena. Qualitative content analysis (QCA) and thematic analysis (TA) as qualitative research approaches are commonly used by researchers across disciplines. There is a gap in the international literature regarding differences between QCA and TA in terms of the concept of a theme and how it is developed. Therefore, in this discussion paper we address this gap in knowledge and present differences and similarities between these qualitative research approaches in terms of the theme as the final product of data analysis. We drew on current multidisciplinary literature to support our perspectives and to develop internationally informed analytical notions of the theme in QCA and TA. We anticipate that improving knowledge and understanding of theme development in QCA and TA will support other researchers in selecting the most appropriate qualitative approach to answer their study question, provide high-quality and trustworthy findings, and remain faithful to the analytical requirements of QCA and TA.

Advances in medicines have increased the effectiveness of treatments and the social and cultural authority of doctors. However, as prescribing has become the dominant modality of treatment, the "pharmaceuticalization" of medical practice has often resulted in treatment "at a distance", with doctors having limited contact with patients. Older and poorer people, who are socially distanced from medical prescribers, suffer more adverse drug reactions (ADRs) than the general population. A team approach to checking patients systematically for ADRs, as detailed in manufacturers' literature, can minimise medication errors, but regular review is rare. This paper explains the benefits of medicines monitoring to protect older patients from iatrogenic harm, such as over-sedation, falls, or drug-induced Parkinsonism. We show how multidisciplinary initiatives to optimise prescribing can be supported by using a recognised resource—the adverse drug reaction profile (ADRe). The profile identifies and documents patients' signs and symptoms of putative ADRs. Better monitoring allows professionals to adjust prescribing and respond to identified problems with agility. Implementation of systematic monitoring will require changes to the regulatory regime and better inter-professional cooperation. Providing carers, nurses and pharmacists with a structured system to monitor patients would democratise relevant medical knowledge and help address ageism and the socio-economic health divide.